TrialCardiovascular drugs and therapy2021

Maxacalcitol (22-Oxacalcitriol (OCT)) Retards Progression of Left Ventricular Hypertrophy with Renal Dysfunction Through Inhibition of Calcineurin-NFAT Activity.

Kazunori Inoue et al.PubMed ↗Publisher ↗

No numbers read from the abstract.